PROFILO, MARIA ANTONIETTA
 Distribuzione geografica
Continente #
NA - Nord America 624
EU - Europa 321
AS - Asia 89
AF - Africa 23
SA - Sud America 2
OC - Oceania 1
Totale 1.060
Nazione #
US - Stati Uniti d'America 610
SE - Svezia 112
IT - Italia 71
CN - Cina 45
DE - Germania 39
BG - Bulgaria 30
GB - Regno Unito 23
FR - Francia 17
CI - Costa d'Avorio 15
SG - Singapore 15
CA - Canada 13
AT - Austria 12
VN - Vietnam 12
IN - India 8
SN - Senegal 7
UA - Ucraina 6
FI - Finlandia 5
HK - Hong Kong 5
RU - Federazione Russa 5
TR - Turchia 2
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
JP - Giappone 1
MA - Marocco 1
PA - Panama 1
Totale 1.060
Città #
Houston 88
Ann Arbor 69
Fairfield 69
Woodbridge 62
Seattle 50
Chandler 48
Ashburn 41
Serra 38
Sofia 30
Cambridge 28
Wilmington 26
Abidjan 15
New York 14
Beijing 12
Ottawa 12
Vienna 12
London 11
Princeton 10
Boardman 9
Bremen 9
Florence 9
Lawrence 9
Dearborn 8
Nanjing 8
Dakar 7
Des Moines 7
Lancaster 7
Marseille 7
Medford 7
Ogden 7
Dong Ket 6
Aosta 5
Hong Kong 4
Kunming 4
Munich 4
Nanchang 4
Singapore 4
Frankfurt am Main 3
Hefei 3
Jüchen 3
Manchester 3
Da Nang 2
Englewood 2
Hebei 2
Izmir 2
Jacksonville 2
Redwood City 2
San Diego 2
San Francisco 2
Brussels 1
Changsha 1
Chengdu 1
Chicago 1
Conshohocken 1
Dallas 1
Düsseldorf 1
Fuzhou 1
Grafing 1
Highland 1
Jinan 1
Lanzhou 1
Melbourne 1
Ningbo 1
Palm City 1
Panama City 1
Pune 1
Rome 1
Santa Clara 1
Santiago 1
Shenyang 1
Tianjin 1
Toronto 1
Totale 811
Nome #
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 149
null 121
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 116
Relationship between serum cholesterol and Graves’ orbitopathy (GO): a confirmatory study 114
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 111
null 97
High Serum Cholesterol Is a Novel Risk Factor for Graves' Orbitopathy: Results of a Cross-Sectional Study 95
null 91
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 74
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 70
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' Orbitopathy 29
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapy 23
Totale 1.090
Categoria #
all - tutte 3.106
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.106


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020178 0 0 0 17 24 32 24 18 21 13 24 5
2020/202188 9 5 4 3 16 1 7 5 12 8 7 11
2021/2022156 1 3 0 11 34 14 2 4 37 14 1 35
2022/2023198 23 44 17 15 14 16 2 12 42 0 11 2
2023/202476 2 5 8 0 10 15 0 11 2 2 13 8
2024/202518 0 11 6 1 0 0 0 0 0 0 0 0
Totale 1.090